Edition:
India

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

84.77USD
18 May 2018
Change (% chg)

$-2.30 (-2.64%)
Prev Close
$87.07
Open
$86.84
Day's High
$86.84
Day's Low
$84.70
Volume
300,573
Avg. Vol
425,675
52-wk High
$106.26
52-wk Low
$71.90

Select another date:

Wed, May 2 2018

UPDATE 3-AmerisourceBergen sees Memphis plant back on track by 2019; shares rise

* Distribution business sales beat, offsetting PharMEDium weakness (Adds details from conference call, background, share movement)

BRIEF-AmerisourceBergen Reports Q2 Earnings Per Share $1.29

* AMERISOURCEBERGEN REPORTS FISCAL 2018 SECOND QUARTER RESULTS

AmerisourceBergen quarterly profit falls 30 percent

May 2 Drug distributor AmerisourceBergen Corp on Wednesday posted a 30 percent fall in second-quarter profit hurt by high operating expenses.

BRIEF-Amerisourcebergen Production At Pharmedium's Memphis Outsourcing Facility Remains Voluntarily Suspended

* PRODUCTION AT PHARMEDIUM'S MEMPHIS OUTSOURCING FACILITY REMAINS VOLUNTARILY SUSPENDED

Kentucky sues drug distributor AmerisourceBergen over opioid epidemic

Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers.

Kentucky sues drug distributor AmerisourceBergen over opioid epidemic

March 8 Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers.

BRIEF-AmerisourceBergen Says Stockholders Rejected Proposal To Urge Board To Report On Governance Measures Implemented Related To Opioids

* AMERISOURCEBERGEN SAYS STOCKHOLDERS REJECTED PROPOSAL TO URGE BOARD TO REPORT ON GOVERNANCE MEASURES IMPLEMENTED RELATED TO OPIOIDS - SEC FILING Source text: (http://bit.ly/2HZhCXW) Further company coverage:

BRIEF-Deal talks between Walgreens and AmerisourceBergen have ended without an agreement- CNBC‍​

* TALKS BETWEEN WALGREENS AND AMERISOURCEBERGEN ABOUT AN ACQUISITION OF THE WHOLESALE DRUG DISTRIBUTOR HAVE ENDED WITHOUT AN AGREEMENT - CNBC, CITING SOURCES‍​ Source text: http://cnb.cx/2HP99qj Further company coverage:

Amerisource deal may not keep Walgreens competitive - analysts

Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative speciality pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.

Amerisource deal may not keep Walgreens competitive: analysts

Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said.

Select another date: